Article Information
History
- June 6, 2020.
Article Versions
- Version 1 (November 22, 2019 - 03:27).
- You are currently viewing Version 2 of this article (June 6, 2020 - 17:33).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kevin M. Maloney1,*,
- Adrien Le Guillou1,2,
- Robert A. Driggers1,§,
- Supriya Sarkar1,3,
- Emeli J. Anderson1,
- Amyn A. Malik1,4,5 and
- Samuel M. Jenness1
- 1Department of Epidemiology, Emory University, Atlanta, GA, USA
- 2Department of Research and Public Health, Reims Teaching Hospitals, Robert Debré Hospital, Reims, France
- 3ViiV Healthcare, Brentford, UK
- 4Yale Institute for Global Health, New Haven, CT
- 5Yale School of Medicine, New Haven, CT
- ↵*CORRESPONDING AUTHOR
: Kevin Maloney, MPH, Department of Epidemiology, Emory University, 1518 Clifton Rd., Atlanta, GA 30322, Email: kevin.maloney{at}emory.edu, Phone: (404) 727-0483, Fax: (404) 712-8392
Posted June 06, 2020.
Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral HIV Pre-Exposure Prophylaxis: A Mathematical Model
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos